Production (Stage)
Amphastar Pharmaceuticals, Inc.
AMPH
$24.47
$0.271.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 141.63M | 159.52M | 157.72M | 166.52M | 154.69M |
| Total Depreciation and Amortization | 58.45M | 57.21M | 56.33M | 55.47M | 48.34M |
| Total Amortization of Deferred Charges | 4.67M | 6.03M | 8.22M | 12.71M | 13.47M |
| Total Other Non-Cash Items | 12.43M | 5.18M | 18.66M | 9.02M | 13.19M |
| Change in Net Operating Assets | -24.00M | -14.55M | -32.70M | -31.12M | -31.28M |
| Cash from Operations | 193.17M | 213.39M | 208.23M | 212.60M | 198.41M |
| Capital Expenditure | -42.95M | -41.04M | -38.07M | -34.47M | -37.48M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -129.00M | -129.00M | -129.00M | -134.58M | -506.41M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 42.26M | 45.11M | -25.23M | -19.82M | -83.66M |
| Cash from Investing | -129.69M | -124.93M | -192.30M | -188.87M | -627.55M |
| Total Debt Issued | 15.99M | 18.43M | 13.57M | 349.06M | 849.08M |
| Total Debt Repaid | -8.20M | -8.26M | -58.30M | -258.33M | -317.79M |
| Issuance of Common Stock | -- | -- | 3.56M | 5.69M | 15.41M |
| Repurchase of Common Stock | -88.68M | -90.31M | -51.69M | -70.00M | -67.31M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -986.00K | -816.00K | -1.33M | -11.18M | -25.33M |
| Cash from Financing | -81.88M | -80.95M | -94.19M | 15.24M | 454.06M |
| Foreign Exchange rate Adjustments | 25.00K | -190.00K | -417.00K | -392.00K | -395.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.37M | 7.31M | -78.69M | 38.57M | 24.53M |